Literature DB >> 18555533

Chickenpox in adults - clinical management.

A J Tunbridge1, J Breuer, K J M Jeffery.   

Abstract

Acute varicella zoster virus (VZV) infection, or chickenpox, is still perceived by many as a mild infection of childhood. However, chickenpox is increasingly common in adults and adolescents who together with immunosuppressed individuals are at a higher risk of severe infection. Antiviral therapy is available which both ameliorates symptoms and decreases the severity of chickenpox if administered early in the course of the infection. Passive immunisation with varicella zoster immunoglobulin (VZIG) may prevent or attenuate infection following exposure to varicella of an immunocompromised or pregnant individual or a neonate. Active immunisation is available and is universal in many developed countries. This review reflects current best practice in management of chickenpox in adults by specialist physicians in the UK. The accompanying flowchart has been formulated to guide emergency physicians and general practitioners through the decision-making process regarding treatment and admission for specialist care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555533     DOI: 10.1016/j.jinf.2008.03.004

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  22 in total

1.  Varicella pneumonia in an immunocompetent adult.

Authors:  Naveen Voore; Richard Lai
Journal:  CMAJ       Date:  2012-05-07       Impact factor: 8.262

2.  Clinical benefits of routine varicella vaccination for adults.

Authors:  Cinzia Germinario; Maria Serena Gallone; Maria Giovanna Cappelli; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT).

Authors:  Joanne F Chou; Nancy A Kernan; Susan Prockop; Glenn Heller; Andromachi Scaradavou; Rachel Kobos; Molly A Knowles; Esperanza B Papadopoulos; Anne Casson; Catherine Copeland; Joanne Torok-Castanza; Nicole Zakak; Julianne Ruggiero; Trudy N Small
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-23       Impact factor: 5.742

4.  The Current State of Vaccine Development for Ocular HSV-1 Infection.

Authors:  D J Royer; A Cohen; Djj Carr
Journal:  Expert Rev Ophthalmol       Date:  2015-04-01

Review 5.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

6.  Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice.

Authors:  Kwok-Hung Chan; Anna J X Zhang; Kelvin K W To; Chris C S Chan; Vincent K M Poon; Kunyuan Guo; Fai Ng; Qi-Wei Zhang; Virtual H C Leung; Annie N Y Cheung; Candy C Y Lau; Patrick C Y Woo; Herman Tse; Wailan Wu; Honglin Chen; Bo-Jian Zheng; Kwok-Yung Yuen
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

7.  Chicken pox in pregnancy : an obstetric concern.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

8.  The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Haedicke; M Quinlivan; S P Steinberg; A A Gershon; K E Brown; J Breuer
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 2.451

9.  Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?

Authors:  Alexander B Beams; Rebecca Bateman; Frederick R Adler
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

Review 10.  Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.

Authors:  Amanda L Verzosa; Lea A McGeever; Shun-Je Bhark; Tracie Delgado; Nicole Salazar; Erica L Sanchez
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.